Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Multiple drugs

Various toxicities: 6 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Sokolov AN, et al. BCR/ABL, IKZF deletions and FLT3-ITD as the targets for relapsed/refractory B-cell acute lymphoblastic leukemia treatment: Blinatumomab combined with Tyrosine kinase inhibitors and ATRA. Cellular Therapy and Transplantation 9: 38-46, No. 1, 2020. Available from: URL: http://doi.org/10.18620/ctt-1866-8836-2020-9-1-38-46 Sokolov AN, et al. BCR/ABL, IKZF deletions and FLT3-ITD as the targets for relapsed/refractory B-cell acute lymphoblastic leukemia treatment: Blinatumomab combined with Tyrosine kinase inhibitors and ATRA. Cellular Therapy and Transplantation 9: 38-46, No. 1, 2020. Available from: URL: http://​doi.​org/​10.​18620/​ctt-1866-8836-2020-9-1-38-46
Metadaten
Titel
Multiple drugs
Various toxicities: 6 case reports
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-81566-2

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Gabapentin